Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Guardant Health Inc
(NQ:
GH
)
27.68
-0.70 (-2.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Guardant Health Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Guardant Health: Return On Capital Employed Insights
June 04, 2021
In Q1, Guardant Health (NASDAQ:GH) posted sales of $78.67 million. Earnings were up 18.31%, but Guardant Health still reported an overall loss of $107.86 million. Guardant Health...
Via
Benzinga
Guardant Health Presents Data at 2021 ASCO Annual Meeting Showing Blood Test Highly Accurate in Detecting Colorectal Cancer in Patients With Early-Stage Cancer
June 04, 2021
From
Guardant Health, Inc.
Via
Business Wire
Cathie Wood Buys $10.5M In Google, Loads Up Another $31.6M In Zoom
June 04, 2021
Cathie Wood-led Ark Investment Management on Thursday bought 4,496 shares, estimated to be worth about $10.55 million, in Google parent Alphabet Inc (NASDAQ: GOOGL) (NASDAQ: GOOG...
Via
Benzinga
Amgen's First KRAS-Targeted Therapy, Lumakras Scores FDA Approval For Lung Cancer
May 28, 2021
The FDA has given accelerated approval to Amgen Inc's (NASDAQ: AMGN) Lumakras (sotorasib) for non-small cell lung cancer (NSCLC) patients harboring kras...
Via
Benzinga
Exposures
Product Safety
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021
June 03, 2021
Upgrades According to B of A Securities, the prior rating for Bloom Energy Corp (NYSE:BE) was changed from Underperform to Neutral. For the first quarter, Bloom Energy had...
Via
Benzinga
Guardant360® CDx Receives FDA Approval as First and Only Liquid Biopsy Companion Diagnostic for Amgen’s LUMAKRAS™ (sotorasib) KRASG12C Inhibitor for Use in Advanced Non-Small Cell Lung Cancer
May 28, 2021
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Files Lawsuit Against Natera for Misleading Oncologists
May 28, 2021
From
Guardant Health, Inc.
Via
Business Wire
Cathie Wood Loads Up Another $292K In SpaceX Partner Velo3D's SPAC
May 26, 2021
Cathie Wood-led Ark Investment Management on Wednesday bought 29,301 shares, estimated to be worth about $292,131, in the SPAC Jaws Spitfire Acquisition Corp (NYSE: SPFR)...
Via
Benzinga
Where Guardant Health Stands With Analysts
May 25, 2021
Guardant Health (NASDAQ:GH) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 1 0 1...
Via
Benzinga
Cathie Wood Buys Another $42M In Twitter Stock, Also Adds DraftKings, Netflix
May 25, 2021
Cathie Wood-led Ark Investment Management on Monday bought 731,775 shares, estimated to be worth about $41.76 million, in Twitter Inc (NYSE: TWTR) — a day after The Bill and...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...
Via
Benzinga
Cathie Wood Loads Up Yet Another $51M In Coinbase As Shares Slump Amid Bitcoin-Led Crypto Carnage
May 23, 2021
Cathie Wood-led Ark Investment Management on Friday snapped up another 223,181 shares, worth about $50.7 million, in Coinbase Global Inc
Via
Benzinga
With Expenses Growing Faster Than Revenue, Is This Cathie Wood Stock in Trouble?
May 22, 2021
Guardant Health released earnings earlier this month, disappointing investors with its sluggish revenue growth and increasing expenses.
Via
The Motley Fool
Exposures
COVID-19
Guardant360® CDx Receives FDA Approval as Companion Diagnostic for Janssen’s RYBREVANT™ (amivantamab-vmjw) for Use in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
May 21, 2021
From
Guardant Health, Inc.
Via
Business Wire
Why Exact Sciences Stock Soared Today
May 20, 2021
The company's Cologuard DNA test appears to be in good shape to maintain its market leadership.
Via
The Motley Fool
Guardant Had Colon Cancer Data, But Rival Exact Popped — Here's Why
May 20, 2021
Guardant and Exact are in a "win-win situation," an analyst said Thursday as EXAS stock surged on a comparison to Guardant in colon cancer detection.
Via
Investor's Business Daily
Guardant Health to Participate in Upcoming June Investor Conferences
May 20, 2021
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Presents Data at 2021 ASCO Annual Meeting Showing Utility of Liquid Biopsy in Early- and Late-Stage Cancers
May 19, 2021
From
Guardant Health, Inc.
Via
Business Wire
Exact Sciences' First-Quarter Results Show Its Strength Under Pressure
May 15, 2021
Despite ongoing pandemic-related headwinds, the medical diagnostic test maker's revenue grew. So how will it perform as those headwinds dissipate?
Via
The Motley Fool
3 Cathie Wood Stocks for a $150 Billion Market That's Just Forming
May 13, 2021
Falling costs are ushering in a new era of screening for a dreaded disease.
Via
The Motley Fool
What 7 Analyst Ratings Have To Say About Guardant Health
May 07, 2021
Guardant Health (NASDAQ:GH) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 0 0 1...
Via
Benzinga
Guardant Health Inc (GH) Q1 2021 Earnings Call Transcript
May 07, 2021
GH earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Thursday's After-Market Session
May 06, 2021
Gainers T2 Biosystems (NASDAQ:TTOO) share...
Via
Benzinga
Guardant Health Reports First Quarter 2021 Financial Results
May 06, 2021
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Appoints Craig Eagle, MD as Chief Medical Officer
May 03, 2021
From
Guardant Health, Inc.
Via
Business Wire
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
Study Shows Guardant Reveal™ Blood-Only Liquid Biopsy Test Predicts Risk for Colorectal Cancer Recurrence with Industry-Leading Sensitivity
April 30, 2021
From
Guardant Health
Via
Business Wire
Guardant Health to Participate in the BofA Securities 2021 Healthcare Conference
April 29, 2021
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Announces Collaboration With Daiichi Sankyo to Develop Guardant360® CDx as a Companion Diagnostic for Enhertu® in Advanced Metastatic Non-Small Cell Lung Cancer
April 27, 2021
From
Guardant Health, Inc.
Via
Business Wire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.